nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomustine—CYP3A4—Vandetanib—thyroid cancer	0.185	0.286	CbGbCtD
Lomustine—CYP2D6—Sorafenib—thyroid cancer	0.176	0.272	CbGbCtD
Lomustine—CYP3A4—Sorafenib—thyroid cancer	0.112	0.173	CbGbCtD
Lomustine—CYP2D6—Doxorubicin—thyroid cancer	0.107	0.165	CbGbCtD
Lomustine—CYP3A4—Doxorubicin—thyroid cancer	0.0678	0.105	CbGbCtD
Lomustine—Gastrointestinal toxicity—Epirubicin—thyroid cancer	0.0236	0.0669	CcSEcCtD
Lomustine—Gastrointestinal toxicity—Doxorubicin—thyroid cancer	0.0218	0.0619	CcSEcCtD
Lomustine—Oropharyngeal discomfort—Sorafenib—thyroid cancer	0.0144	0.0408	CcSEcCtD
Lomustine—Neoplasm—Vandetanib—thyroid cancer	0.0141	0.0398	CcSEcCtD
Lomustine—Acute leukaemia—Epirubicin—thyroid cancer	0.0136	0.0384	CcSEcCtD
Lomustine—Acute leukaemia—Doxorubicin—thyroid cancer	0.0125	0.0355	CcSEcCtD
Lomustine—Lethargy—Vandetanib—thyroid cancer	0.0115	0.0326	CcSEcCtD
Lomustine—Neoplasm—Sorafenib—thyroid cancer	0.00948	0.0268	CcSEcCtD
Lomustine—Renal failure—Vandetanib—thyroid cancer	0.00855	0.0242	CcSEcCtD
Lomustine—Stomatitis—Vandetanib—thyroid cancer	0.00847	0.024	CcSEcCtD
Lomustine—Myelosuppression—Epirubicin—thyroid cancer	0.00826	0.0234	CcSEcCtD
Lomustine—Haemoglobin—Vandetanib—thyroid cancer	0.00784	0.0222	CcSEcCtD
Lomustine—Haemorrhage—Vandetanib—thyroid cancer	0.0078	0.0221	CcSEcCtD
Lomustine—Myelosuppression—Doxorubicin—thyroid cancer	0.00764	0.0217	CcSEcCtD
Lomustine—Visual impairment—Vandetanib—thyroid cancer	0.00752	0.0213	CcSEcCtD
Lomustine—Blindness—Epirubicin—thyroid cancer	0.007	0.0198	CcSEcCtD
Lomustine—Alopecia—Vandetanib—thyroid cancer	0.0069	0.0195	CcSEcCtD
Lomustine—Blindness—Doxorubicin—thyroid cancer	0.00647	0.0183	CcSEcCtD
Lomustine—Renal failure—Sorafenib—thyroid cancer	0.00576	0.0163	CcSEcCtD
Lomustine—Stomatitis—Sorafenib—thyroid cancer	0.00572	0.0162	CcSEcCtD
Lomustine—Infection—Vandetanib—thyroid cancer	0.00551	0.0156	CcSEcCtD
Lomustine—Thrombocytopenia—Vandetanib—thyroid cancer	0.00543	0.0154	CcSEcCtD
Lomustine—Haemoglobin—Sorafenib—thyroid cancer	0.00529	0.015	CcSEcCtD
Lomustine—Haemorrhage—Sorafenib—thyroid cancer	0.00526	0.0149	CcSEcCtD
Lomustine—Decreased appetite—Vandetanib—thyroid cancer	0.00482	0.0137	CcSEcCtD
Lomustine—Alopecia—Sorafenib—thyroid cancer	0.00465	0.0132	CcSEcCtD
Lomustine—Body temperature increased—Vandetanib—thyroid cancer	0.00438	0.0124	CcSEcCtD
Lomustine—Leukopenia—Sorafenib—thyroid cancer	0.0041	0.0116	CcSEcCtD
Lomustine—Dysarthria—Epirubicin—thyroid cancer	0.0041	0.0116	CcSEcCtD
Lomustine—Dysarthria—Doxorubicin—thyroid cancer	0.00379	0.0107	CcSEcCtD
Lomustine—Infection—Sorafenib—thyroid cancer	0.00372	0.0105	CcSEcCtD
Lomustine—Thrombocytopenia—Sorafenib—thyroid cancer	0.00366	0.0104	CcSEcCtD
Lomustine—Anorexia—Sorafenib—thyroid cancer	0.00357	0.0101	CcSEcCtD
Lomustine—Vomiting—Vandetanib—thyroid cancer	0.00353	0.00998	CcSEcCtD
Lomustine—Neoplasm—Epirubicin—thyroid cancer	0.0035	0.00992	CcSEcCtD
Lomustine—Nausea—Vandetanib—thyroid cancer	0.00329	0.00933	CcSEcCtD
Lomustine—Decreased appetite—Sorafenib—thyroid cancer	0.00325	0.00921	CcSEcCtD
Lomustine—Neoplasm—Doxorubicin—thyroid cancer	0.00324	0.00918	CcSEcCtD
Lomustine—Body temperature increased—Sorafenib—thyroid cancer	0.00296	0.00837	CcSEcCtD
Lomustine—Lethargy—Epirubicin—thyroid cancer	0.00287	0.00813	CcSEcCtD
Lomustine—Osteoarthritis—Epirubicin—thyroid cancer	0.00281	0.00797	CcSEcCtD
Lomustine—Lethargy—Doxorubicin—thyroid cancer	0.00266	0.00752	CcSEcCtD
Lomustine—Ataxia—Epirubicin—thyroid cancer	0.00264	0.00749	CcSEcCtD
Lomustine—Osteoarthritis—Doxorubicin—thyroid cancer	0.0026	0.00737	CcSEcCtD
Lomustine—Ataxia—Doxorubicin—thyroid cancer	0.00245	0.00693	CcSEcCtD
Lomustine—Vomiting—Sorafenib—thyroid cancer	0.00238	0.00674	CcSEcCtD
Lomustine—Pancytopenia—Epirubicin—thyroid cancer	0.00231	0.00654	CcSEcCtD
Lomustine—Nausea—Sorafenib—thyroid cancer	0.00222	0.00629	CcSEcCtD
Lomustine—Pancytopenia—Doxorubicin—thyroid cancer	0.00214	0.00605	CcSEcCtD
Lomustine—Renal failure—Epirubicin—thyroid cancer	0.00213	0.00603	CcSEcCtD
Lomustine—Stomatitis—Epirubicin—thyroid cancer	0.00211	0.00598	CcSEcCtD
Lomustine—Renal failure—Doxorubicin—thyroid cancer	0.00197	0.00558	CcSEcCtD
Lomustine—Haemoglobin—Epirubicin—thyroid cancer	0.00196	0.00554	CcSEcCtD
Lomustine—Stomatitis—Doxorubicin—thyroid cancer	0.00195	0.00554	CcSEcCtD
Lomustine—Haemorrhage—Epirubicin—thyroid cancer	0.00195	0.00551	CcSEcCtD
Lomustine—Visual impairment—Epirubicin—thyroid cancer	0.00187	0.00531	CcSEcCtD
Lomustine—Haemoglobin—Doxorubicin—thyroid cancer	0.00181	0.00512	CcSEcCtD
Lomustine—Haemorrhage—Doxorubicin—thyroid cancer	0.0018	0.0051	CcSEcCtD
Lomustine—Visual impairment—Doxorubicin—thyroid cancer	0.00173	0.00491	CcSEcCtD
Lomustine—Alopecia—Epirubicin—thyroid cancer	0.00172	0.00487	CcSEcCtD
Lomustine—Alopecia—Doxorubicin—thyroid cancer	0.00159	0.00451	CcSEcCtD
Lomustine—Leukopenia—Epirubicin—thyroid cancer	0.00152	0.00429	CcSEcCtD
Lomustine—Leukopenia—Doxorubicin—thyroid cancer	0.0014	0.00397	CcSEcCtD
Lomustine—Infection—Epirubicin—thyroid cancer	0.00137	0.00389	CcSEcCtD
Lomustine—Thrombocytopenia—Epirubicin—thyroid cancer	0.00135	0.00383	CcSEcCtD
Lomustine—Anorexia—Epirubicin—thyroid cancer	0.00132	0.00373	CcSEcCtD
Lomustine—Infection—Doxorubicin—thyroid cancer	0.00127	0.0036	CcSEcCtD
Lomustine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00125	0.00355	CcSEcCtD
Lomustine—Anorexia—Doxorubicin—thyroid cancer	0.00122	0.00345	CcSEcCtD
Lomustine—Decreased appetite—Epirubicin—thyroid cancer	0.0012	0.0034	CcSEcCtD
Lomustine—Decreased appetite—Doxorubicin—thyroid cancer	0.00111	0.00315	CcSEcCtD
Lomustine—Body temperature increased—Epirubicin—thyroid cancer	0.00109	0.00309	CcSEcCtD
Lomustine—Body temperature increased—Doxorubicin—thyroid cancer	0.00101	0.00286	CcSEcCtD
Lomustine—Vomiting—Epirubicin—thyroid cancer	0.000879	0.00249	CcSEcCtD
Lomustine—Nausea—Epirubicin—thyroid cancer	0.000821	0.00233	CcSEcCtD
Lomustine—Vomiting—Doxorubicin—thyroid cancer	0.000813	0.0023	CcSEcCtD
Lomustine—Nausea—Doxorubicin—thyroid cancer	0.00076	0.00215	CcSEcCtD
